NCT01403090View on ClinicalTrials.gov

Safety Study of the Angel™ Catheter in Subjects With Risk of Pulmonary Embolism

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Pulmonary EmbolismDeep Vein ThrombosisVenous Thromboembolism
Interventions
DEVICE

Angel Catheter

The Angel Catheter will be inserted in the femoral vein following standard central line placement techniques. Once the catheter is on the Inferior Vena Cava, the filter will be deployed following the manufacturer instructions and secured to the skin.

Trial Locations (2)

Unknown

Clinica las Americas, Medellín

Hospital Pablo Tobon Uribe, Medellín

Sponsors

Lead Sponsor

BiO2 Medical
All Listed Sponsors
lead

BiO2 Medical

INDUSTRY

NCT01403090 - Safety Study of the Angel™ Catheter in Subjects With Risk of Pulmonary Embolism | Biotech Hunter | Biotech Hunter